Cytochrome P450-dependent n-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, β-naphthoflavone and l-deprenyl
Identifieur interne : 001C46 ( Main/Exploration ); précédent : 001C45; suivant : 001C47Cytochrome P450-dependent n-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, β-naphthoflavone and l-deprenyl
Auteurs : Massimo Valoti [Italie] ; Fabio Fusi [Italie] ; Maria Frosini [Italie] ; Federica Pessina [Italie] ; Keith F. Tipton [Irlande (pays)] ; Gian P. Sgaragli [Italie]Source :
- European Journal of Pharmacology [ 0014-2999 ] ; 2000.
English descriptors
- KwdEn :
Abstract
The monoamine oxidase inhibitor l-deprenyl [(−)-deprenyl, selegiline] is an effective therapeutic agent for improving early symptoms of idiopathic Parkinson's disease. It appears to exert this action independently of its inhibition of monoamine oxidase B (MAO-B) and some of its metabolites are thought to contribute. Cytochrome P450 (CYP) activities are known to give rise to l-deprenyl metabolites that may affect the dopaminergic system. In order to clarify the interactions of l-deprenyl with these enzymes, C57BL mice were treated with l-deprenyl, ethanol, phenobarbital or β-naphthoflavone to induce different CYP isozymes. After preincubation of l-deprenyl with liver microsomes from control or treated mice, the metabolites were analysed by a GLC method. l-deprenyl (10 mg/kg i.p. for 3 days) caused a significant decrease in total CYP levels (0.315±0.019, l-deprenyl; 0.786±0.124, control, nmol/mg protein) and CYP2E1-associated p-nitrophenol hydroxylase activity (0.92±0.04 vs. 1.17±0.06 nmol/min/mg). Both phenobarbital and ethanol increased the N-depropynylation activity towards l-deprenyl that leads to the formation of methamphetamine (4.11±0.64, phenobarbital; 4.77±1.15, ethanol; 1.77±0.34, control, nmol/min/mg). Ethanol alone increased the N-demethylation rate of l-deprenyl, that results in formation of nordeprenyl (3.99±0.68, ethanol; 1.41±0.31, control, nmol/min/mg). Moreover, the N-dealkylation pathways of deprenyl are inhibited by 4-methylpyrazole and disulfiram, two CYP2E1 inhibitors. None of the other treatments modified l-deprenyl metabolism. These findings indicate that mainly CYP2E1 and to a lesser extent CYP2B isozymes are involved in l-deprenyl metabolism. They also suggest that, by reducing CYP content, l-deprenyl treatment may impair the metabolic disposition of other drugs given in combination regimens.
Url:
DOI: 10.1016/S0014-2999(00)00078-9
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Cytochrome P450-dependent n-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, β-naphthoflavone and l-deprenyl</title><author><name sortKey="Valoti, Massimo" sort="Valoti, Massimo" uniqKey="Valoti M" first="Massimo" last="Valoti">Massimo Valoti</name></author><author><name sortKey="Fusi, Fabio" sort="Fusi, Fabio" uniqKey="Fusi F" first="Fabio" last="Fusi">Fabio Fusi</name></author><author><name sortKey="Frosini, Maria" sort="Frosini, Maria" uniqKey="Frosini M" first="Maria" last="Frosini">Maria Frosini</name></author><author><name sortKey="Pessina, Federica" sort="Pessina, Federica" uniqKey="Pessina F" first="Federica" last="Pessina">Federica Pessina</name></author><author><name sortKey="Tipton, Keith F" sort="Tipton, Keith F" uniqKey="Tipton K" first="Keith F" last="Tipton">Keith F. Tipton</name></author><author><name sortKey="Sgaragli, Gian P" sort="Sgaragli, Gian P" uniqKey="Sgaragli G" first="Gian P" last="Sgaragli">Gian P. Sgaragli</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:9F8D6F9442915C756F0EBDFBC1CA15D454797787</idno><date when="2000" year="2000">2000</date><idno type="doi">10.1016/S0014-2999(00)00078-9</idno><idno type="url">https://api.istex.fr/document/9F8D6F9442915C756F0EBDFBC1CA15D454797787/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001492</idno><idno type="wicri:Area/Main/Curation">001271</idno><idno type="wicri:Area/Main/Exploration">001C46</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Cytochrome P450-dependent n-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, β-naphthoflavone and l-deprenyl</title><author><name sortKey="Valoti, Massimo" sort="Valoti, Massimo" uniqKey="Valoti M" first="Massimo" last="Valoti">Massimo Valoti</name><affiliation wicri:level="1"><country wicri:rule="url">Italie</country></affiliation><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Scienze Farmacologiche, Università degli Studi di Siena, via Piccolomini 170, 53100 Siena</wicri:regionArea><wicri:noRegion>53100 Siena</wicri:noRegion></affiliation></author><author><name sortKey="Fusi, Fabio" sort="Fusi, Fabio" uniqKey="Fusi F" first="Fabio" last="Fusi">Fabio Fusi</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Scienze Farmacologiche, Università degli Studi di Siena, via Piccolomini 170, 53100 Siena</wicri:regionArea><wicri:noRegion>53100 Siena</wicri:noRegion></affiliation></author><author><name sortKey="Frosini, Maria" sort="Frosini, Maria" uniqKey="Frosini M" first="Maria" last="Frosini">Maria Frosini</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Scienze Farmacologiche, Università degli Studi di Siena, via Piccolomini 170, 53100 Siena</wicri:regionArea><wicri:noRegion>53100 Siena</wicri:noRegion></affiliation></author><author><name sortKey="Pessina, Federica" sort="Pessina, Federica" uniqKey="Pessina F" first="Federica" last="Pessina">Federica Pessina</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Scienze Farmacologiche, Università degli Studi di Siena, via Piccolomini 170, 53100 Siena</wicri:regionArea><wicri:noRegion>53100 Siena</wicri:noRegion></affiliation></author><author><name sortKey="Tipton, Keith F" sort="Tipton, Keith F" uniqKey="Tipton K" first="Keith F" last="Tipton">Keith F. Tipton</name><affiliation wicri:level="1"><country xml:lang="fr">Irlande (pays)</country><wicri:regionArea>Department of Biochemistry, Trinity College, Dublin 2</wicri:regionArea><wicri:noRegion>Dublin 2</wicri:noRegion></affiliation></author><author><name sortKey="Sgaragli, Gian P" sort="Sgaragli, Gian P" uniqKey="Sgaragli G" first="Gian P" last="Sgaragli">Gian P. Sgaragli</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Istituto di Scienze Farmacologiche, Università degli Studi di Siena, via Piccolomini 170, 53100 Siena</wicri:regionArea><wicri:noRegion>53100 Siena</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">European Journal of Pharmacology</title><title level="j" type="abbrev">EJP</title><idno type="ISSN">0014-2999</idno><imprint><publisher>ELSEVIER</publisher><date type="published" when="2000">2000</date><biblScope unit="volume">391</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="199">199</biblScope><biblScope unit="page" to="206">206</biblScope></imprint><idno type="ISSN">0014-2999</idno></series><idno type="istex">9F8D6F9442915C756F0EBDFBC1CA15D454797787</idno><idno type="DOI">10.1016/S0014-2999(00)00078-9</idno><idno type="PII">S0014-2999(00)00078-9</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0014-2999</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>C57BL mouse liver microsomal preparation</term><term>Cytochrome P450</term><term>Deprenyl metabolism</term><term>N-dealkylation pathway</term><term>Parkinson's disease</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The monoamine oxidase inhibitor l-deprenyl [(−)-deprenyl, selegiline] is an effective therapeutic agent for improving early symptoms of idiopathic Parkinson's disease. It appears to exert this action independently of its inhibition of monoamine oxidase B (MAO-B) and some of its metabolites are thought to contribute. Cytochrome P450 (CYP) activities are known to give rise to l-deprenyl metabolites that may affect the dopaminergic system. In order to clarify the interactions of l-deprenyl with these enzymes, C57BL mice were treated with l-deprenyl, ethanol, phenobarbital or β-naphthoflavone to induce different CYP isozymes. After preincubation of l-deprenyl with liver microsomes from control or treated mice, the metabolites were analysed by a GLC method. l-deprenyl (10 mg/kg i.p. for 3 days) caused a significant decrease in total CYP levels (0.315±0.019, l-deprenyl; 0.786±0.124, control, nmol/mg protein) and CYP2E1-associated p-nitrophenol hydroxylase activity (0.92±0.04 vs. 1.17±0.06 nmol/min/mg). Both phenobarbital and ethanol increased the N-depropynylation activity towards l-deprenyl that leads to the formation of methamphetamine (4.11±0.64, phenobarbital; 4.77±1.15, ethanol; 1.77±0.34, control, nmol/min/mg). Ethanol alone increased the N-demethylation rate of l-deprenyl, that results in formation of nordeprenyl (3.99±0.68, ethanol; 1.41±0.31, control, nmol/min/mg). Moreover, the N-dealkylation pathways of deprenyl are inhibited by 4-methylpyrazole and disulfiram, two CYP2E1 inhibitors. None of the other treatments modified l-deprenyl metabolism. These findings indicate that mainly CYP2E1 and to a lesser extent CYP2B isozymes are involved in l-deprenyl metabolism. They also suggest that, by reducing CYP content, l-deprenyl treatment may impair the metabolic disposition of other drugs given in combination regimens.</div></front></TEI><affiliations><list><country><li>Irlande (pays)</li><li>Italie</li></country></list><tree><country name="Italie"><noRegion><name sortKey="Valoti, Massimo" sort="Valoti, Massimo" uniqKey="Valoti M" first="Massimo" last="Valoti">Massimo Valoti</name></noRegion><name sortKey="Frosini, Maria" sort="Frosini, Maria" uniqKey="Frosini M" first="Maria" last="Frosini">Maria Frosini</name><name sortKey="Fusi, Fabio" sort="Fusi, Fabio" uniqKey="Fusi F" first="Fabio" last="Fusi">Fabio Fusi</name><name sortKey="Pessina, Federica" sort="Pessina, Federica" uniqKey="Pessina F" first="Federica" last="Pessina">Federica Pessina</name><name sortKey="Sgaragli, Gian P" sort="Sgaragli, Gian P" uniqKey="Sgaragli G" first="Gian P" last="Sgaragli">Gian P. Sgaragli</name><name sortKey="Valoti, Massimo" sort="Valoti, Massimo" uniqKey="Valoti M" first="Massimo" last="Valoti">Massimo Valoti</name></country><country name="Irlande (pays)"><noRegion><name sortKey="Tipton, Keith F" sort="Tipton, Keith F" uniqKey="Tipton K" first="Keith F" last="Tipton">Keith F. Tipton</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001C46 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001C46 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:9F8D6F9442915C756F0EBDFBC1CA15D454797787
|texte= Cytochrome P450-dependent n-dealkylation of l-deprenyl in C57BL mouse liver microsomes: effects of in vivo pretreatment with ethanol, phenobarbital, β-naphthoflavone and l-deprenyl
}}
| This area was generated with Dilib version V0.6.23. |  |